These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19715526)

  • 1. Tamoxifen therapy in kidney-transplant patients presenting with severe encapsulating peritoneal sclerosis after treatment for acute humoral rejection.
    Mohamed AO; Kamar N; Nogier MB; Esposito L; Duffas JP; Rostaing L
    Exp Clin Transplant; 2009 Sep; 7(3):164-7. PubMed ID: 19715526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effectiveness of everolimus plus tamoxifen therapy in treatment of encapsulating peritoneal sclerosis.
    Huddam B; Azak A; Koçak G; Başaran M; Voyvoda N; Duranay M
    Ren Fail; 2012; 34(3):387-9. PubMed ID: 22263915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen therapy in encapsulating sclerosing peritonitis in patients after kidney transplantation.
    Moustafellos P; Hadjianastassiou V; Roy D; Velzeboer NE; Maniakyn N; Vaidya A; Friend PJ
    Transplant Proc; 2006 Nov; 38(9):2913-4. PubMed ID: 17112862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant encapsulating peritoneal sclerosis: presentation of cases and review of the literature.
    Dębska-Ślizien A; Konopa J; Januszko-Giergielewicz B; Wołyniec Z; Wołyniec W; Chamienia A; Rutkowski B
    J Nephrol; 2013; 26(5):906-11. PubMed ID: 23065918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for everolimus in post-transplant encapsulating peritoneal sclerosis: first case report.
    Sud R; Garry L; Spicer ST; Allen RD; Eris JM; Wyburn K; Verran D; Cooper CL; Chadban S
    Nephrology (Carlton); 2014 Apr; 19 Suppl 1():27-30. PubMed ID: 24460661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulating peritoneal sclerosis in a peritoneal dialysis patient presenting with complicated Mycobacterium fortuitum peritonitis.
    Simbli MA; Niaz FA; Al-Wakeel JS
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):635-41. PubMed ID: 22569461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study.
    Korte MR; Fieren MW; Sampimon DE; Lingsma HF; Weimar W; Betjes MG;
    Nephrol Dial Transplant; 2011 Feb; 26(2):691-7. PubMed ID: 20584735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR inhibitors for management of encapsulating peritoneal sclerosis: a review of literatures.
    Ghadimi M; Dashti-Khavidaki S; Khalili H
    Ren Fail; 2016 Nov; 38(10):1574-1580. PubMed ID: 27425661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of encapsulating peritoneal sclerosis following bacterial peritonitis in a peritoneal dialysis patient.
    Hsu YH; Hsia CC; Tsai DM; Tu HY; Hung KY; Huang JW
    Am J Kidney Dis; 2010 Jan; 55(1):198-202. PubMed ID: 19782452
    [No Abstract]   [Full Text] [Related]  

  • 10. Fifteen cases of encapsulating peritoneal sclerosis related to peritoneal dialysis: a single-center experience in Japan.
    Yamamoto H; Nakayama M; yamamoto R; Otsuka Y; Takahashi H; Kato N; Hayakawa H; Hasegawa T; Ikeda M; Yokoyama K; Kawaguchi Y; Mukai H; Hosoya T
    Adv Perit Dial; 2002; 18():135-8. PubMed ID: 12402605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients.
    Ekim M; Fitöz S; Yagmurlu A; Ensari A; Yüksel S; Acar B; Ozçakar ZB; Kendirli T; Bingöler B; Yalçinkaya F
    Nephrology (Carlton); 2005 Aug; 10(4):341-3. PubMed ID: 16109078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR inhibitors for medical treatment of post-transplantation encapsulating peritoneal sclerosis: a favourable single center experience.
    Messina M; Ariaudo C; Mella A; Cantaluppi V; Segoloni GP; Biancone L
    J Nephrol; 2015 Apr; 28(2):245-9. PubMed ID: 25585825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulating peritoneal sclerosis in patients on peritoneal dialysis in Slovenia.
    Lindic J; Rupnik AT; Tomazic J; Skoberne A; Gucek A; Ferluga D; Pintar T; Ales A; Kovac D; Kveder R; Pajek J; Savicki-Ponikvar B; Bren A
    Ther Apher Dial; 2009 Aug; 13(4):282-7. PubMed ID: 19695060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulating peritoneal sclerosis: experience of a tertiary referral center.
    Phelan PJ; Walshe JJ; Al-Aradi A; Garvey JP; Finnegan K; O'Kelly P; McWilliams J; Ti JP; Morrin MM; Morgan N; Conlon PJ
    Ren Fail; 2010 May; 32(4):459-63. PubMed ID: 20446784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of plasmapheresis for acute humoral rejection after heart transplantation.
    Wang SS; Chou NK; Ko WJ; Chi NH; Hung SC; Hsu RB; Yu HY; Chen YS; Chu SH; Tsao CI; Shun CT
    Transplant Proc; 2006 Dec; 38(10):3692-4. PubMed ID: 17175369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulating peritoneal sclerosis--a complication of peritoneal dialysis.
    Chembo C; Macdonald A; Hay N; Matheson P; Pidgeon G; Leikis M
    N Z Med J; 2011 Sep; 124(1342):89-93. PubMed ID: 21963929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.
    Balasubramaniam G; Brown EA; Davenport A; Cairns H; Cooper B; Fan SL; Farrington K; Gallagher H; Harnett P; Krausze S; Steddon S
    Nephrol Dial Transplant; 2009 Oct; 24(10):3209-15. PubMed ID: 19211652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplantation encapsulating peritoneal sclerosis in a young child.
    Tan R; Betjes M; Cransberg K
    Nephrol Dial Transplant; 2011 Nov; 26(11):3822-4. PubMed ID: 21821834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulating peritoneal sclerosis: surgery, sustained drug therapy and treatment of recurrence at 1 year.
    Cho R; Ghag D; Karim MA; Lo C
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26561223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peritoneal dialysis: a time-limited therapy because of encapsulating peritoneal sclerosis? No, but better approaches are available].
    Garosi G
    G Ital Nefrol; 2010; 27(5):456-63. PubMed ID: 20922676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.